Curanex Pharmaceuticals Inc Common Stock (CURX) vs Exicure, Inc. (XCUR)
A side-by-side comparison of Curanex Pharmaceuticals Inc Common Stock and Exicure, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CURX
Curanex Pharmaceuticals Inc Common Stock
$4.99HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XCUR
Exicure, Inc.
$1.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CURX vs XCUR
growth of $100 · dividends reinvested · last 1yCURX -93.8% (-93.8%/yr)XCUR -81.9% (-81.9%/yr)XCUR compounded faster over this window
CURX XCUR
CURX vs XCUR: by the numbers
- •CURX is the larger company ($7M vs $7M market cap).
Metrics side by side
Valuation
| Metric | CURX | XCUR |
|---|---|---|
| P/B ratio | 1.48 | 7.05 |
Profitability
| Metric | CURX | XCUR |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -218.65% | -847.90% |
| ROIC | -208.39% | -101.07% |
Growth (annualized)
| Metric | CURX | XCUR |
|---|---|---|
| Total return CAGR (5Y) | N/A | -64.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.